Literature DB >> 16769952

Rapid infusion of cold saline (4 degrees C) as adjunctive treatment of fever in patients with brain injury.

Neeraj Badjatia1, Michael Bodock, M Guanci, G A Rordorf.   

Abstract

The use of rapid infusion of large-volume cold saline (CS) as an adjunctive therapy for treating refractory fever in nine patients is reported. A decline in temperature (39.2 +/- 0.3 vs 37.1 +/- 1.2 degrees C, p = 0.006) at 2 hours and fever burden (97.3 +/- 343.8 vs 734.3 +/- 422.3 degrees C*min, p = 0.02) at 12 hours was noted after CS bolus. Rapid infusion of large-volume CS may be used as an adjunct for inducing normothermia in refractory febrile patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16769952     DOI: 10.1212/01.wnl.0000218166.54150.0a

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Safety, Feasibility, and Efficiency of a New Cooling Device Using Intravenous Cold Infusions for Fever Control.

Authors:  J F Willms; O Boss; E Keller
Journal:  Neurocrit Care       Date:  2019-02       Impact factor: 3.210

Review 2.  The Implementation of Targeted Temperature Management: An Evidence-Based Guideline from the Neurocritical Care Society.

Authors:  Lori Kennedy Madden; Michelle Hill; Teresa L May; Theresa Human; Mary McKenna Guanci; Judith Jacobi; Melissa V Moreda; Neeraj Badjatia
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

3.  Meta-Analysis on the Effect of Hypothermia in Acute Spinal Cord Injury.

Authors:  Hong Kyung Shin; Jin Hoon Park; Sung Woo Roh; Sang Ryong Jeon
Journal:  Neurospine       Date:  2022-09-30

4.  Hypothermia for refractory status epilepticus.

Authors:  Jesse J Corry; Rajat Dhar; Theresa Murphy; Michael N Diringer
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

5.  Effect of a fever control protocol-based strategy on ventilator-associated pneumonia in severely brain-injured patients.

Authors:  Yoann Launey; Nicolas Nesseler; Audren Le Cousin; Fanny Feuillet; Ronan Garlantezec; Yannick Mallédant; Philippe Seguin
Journal:  Crit Care       Date:  2014-12-15       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.